Maravai LifeSciences set to acquire DNA and RNA business from Officinae Bio

Deal News | Nov 11, 2024 | PedersoliGattai

Maravai LifeSciences, a US-listed company specializing in scientific services for biotechnology, has announced their agreement to acquire the DNA and RNA business from Officinae Bio, an Italian private tech enterprise known for its digital platform supporting innovative therapy design. This transaction, expected to close in early 2025, is pending certain conditions. Legal advisor PedersoliGattai guided Maravai LifeSciences through this acquisition, deploying a multidisciplinary team led by partner Gerardo Gabrielli. Key team members included Cristina Riva and Chiara Guidi, who focused on corporate issues, while Nicola Martegani and Clara Balboni handled due diligence. Davide Cacchioli, Alessandro Bardanzellu, and Martina Oricco served Maravai on antitrust and governmental control matters.

Sectors

  • Biotechnology
  • Legal Services

Geography

  • United States – Maravai LifeSciences is a US-based company, and this location is relevant to the transaction due to its headquarters and operation base.
  • Italy – Officinae Bio, the company being acquired, is based in Italy, making this location significant to the transaction.

Industry

  • Biotechnology – This industry is relevant as Maravai LifeSciences and Officinae Bio operate within biotechnology, focusing on DNA and RNA innovations.
  • Legal Services – PedersoliGattai's involvement as legal advisors highlights the legal services sector's role in facilitating complex international mergers and acquisitions.

Financials

    Participants

    NameRoleTypeDescription
    Maravai LifeSciences, Inc.Bidding Company/BuyerCompanyA US-listed company that supplies catalyst and life science services to biotechnology researchers and innovators.
    Officinae BioTarget CompanyCompanyAn Italian private technology company with a digital platform supporting biological design innovations.
    PedersoliGattaiLegal AdvisorCompanyLegal advisors facilitating the acquisition process for Maravai LifeSciences.
    Gerardo GabrielliPartnerPersonPartner at PedersoliGattai leading the cross-practice legal advisory team.
    Cristina RivaCounselPersonCounsel at PedersoliGattai, managed corporate aspects of the transaction.
    Chiara GuidiAssociatePersonAssociate at PedersoliGattai, involved in handling corporate aspects.
    Nicola MarteganiSenior CounselPersonSenior Counsel at PedersoliGattai, focused on due diligence.
    Clara BalboniSenior AssociatePersonSenior Associate at PedersoliGattai, involved in due diligence tasks.
    Davide CacchioliPartnerPersonPartner at PedersoliGattai, overseeing the antitrust and golden power aspects.
    Alessandro BardanzelluSalary PartnerPersonSalary Partner at PedersoliGattai, assisted on antitrust matters.
    Martina OriccoAssociatePersonAssociate at PedersoliGattai, contributed to antitrust and golden power assessments.